Menopause, wellbeing and health: A care pathway from the European Menopause and Andropause Society.

Autor: Lambrinoudaki I; Second Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, Greece. Electronic address: ilambrinoudaki@med.uoa.gr., Armeni E; Second Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, Greece., Goulis D; Unit of Reproductive Endocrinology, First Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Greece., Bretz S; Clinica Silvia Bretz, Rio de Janeiro, Brazil., Ceausu I; Department of Obstetrics and Gynecology I, 'Carol Davila' University of Medicine and Pharmacy, 'Dr. I. Cantacuzino' Clinical Hospital, Bucharest, Romania., Durmusoglu F; Istanbul Medipol International School of Medicine, Istanbul, Turkey., Erkkola R; Department of Obstetrics and Gynecology, University Central Hospital, Turku, Finland., Fistonic I; Institute for Women's Health, Zagreb, Croatia., Gambacciani M; Menopause and Osteoporosis Unit, San Rossore Clinical Center, Pisa, Italy., Geukes M; Department of Obstetrics and Gynecology, Ziekenhuisgroep Twente (Hospital Group Twente), Post Box 7600, 7600 SZ Almelo, the Netherlands., Hamoda H; Department Gynaecology, King's College Hospital, Denmark Hill, London SE5 9RS, UK., Hartley C; Menopause Health Clinic, Dublin, Ireland., Hirschberg AL; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden; Department of Gynecology and Reproductive Medicine, Karolinska University Hospital, Stockholm, Sweden., Meczekalski B; Department of Gynecological Endocrinology, Poznan University of Medical Sciences, Poznan, Poland., Mendoza N; Department of Obstetrics and Gynecology, University of Granada, Spain., Mueck A; Department of Women's Health, University Hospital Tuebingen, Germany; Beijing OB/GYN Hospital, Capital Medical University, China., Smetnik A; Department of Gynecological Endocrinology, National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Healthcare of the Russian Federation, Moscow, Russia., Stute P; Department of Obstetrics and Gynecology, University Clinic Inselspital, Bern, Switzerland., van Trotsenburg M; Department of Obstetrics and Gynecology, University Hospital St. Poelten-Lilienfeld, Austria., Rees M; Women's Centre, John Radcliffe Hospital, Oxford OX3 9DU, UK.
Jazyk: angličtina
Zdroj: Maturitas [Maturitas] 2022 Sep; Vol. 163, pp. 1-14. Date of Electronic Publication: 2022 May 12.
DOI: 10.1016/j.maturitas.2022.04.008
Abstrakt: This care pathway from the European Menopause and Andropause Society (EMAS) provides an updated pathway for monitoring and guidance of women at midlife, focusing on those approaching the end of the reproductive life-cycle, going through the menopausal transition and beyond. The care pathway is written by professionals involved in women's health and provides a stepwise individualized approach, stratified according to needs, symptoms and reproductive stage. Furthermore, the pathway provides details on screening for chronic diseases related to menopause and ageing. Treatment options for climacteric symptoms range from menopausal hormone therapy to non-hormonal alternatives and lifestyle modifications. Therapy should be tailored to personal needs and wishes. The pathway aims to offer a holistic, balanced approach for monitoring middle-aged women, aiming to control health problems effectively and ensure healthy ageing.
Competing Interests: 1. Irene Lambrinoudaki: None declared. 2.Eleni Armeni: None declared. 3. Dimitrios G. Goulis: None declared. 4. Silvia Bretz: None declared.5. Iuliana Ceausu: None declared. 6. Fatih Durmusoglu: None declared. 7. Risto Erkkola: None declared. 8. Ivan Fistonic: has received consulting fees in the past 3 years from Fotona Inc. 9. Marco Gambacciani: has received speaker and consulting fees in the past 3 years from MSD, Theramex and Bayer. 10. Marije Geukes: None declared. 11. Haitham Hamoda: None declared. 12. Caiomhe Hartley: None declared. 13. Angelica Lindén Hirschberg in the past 3 years has received grant support from ITF Research Pharma for the “Blissafe” study.
(Copyright © 2022 Elsevier B.V. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: